Please use this identifier to cite or link to this item:
Title: Serum CA 125 combined with transvaginal ultrasonography for ovarian cancer screening
Authors: Roupa, Zoi
Faros, Efthimios
Tzavelas, George
Kotrotsiou, Evangelia 
Sotiropoulou, Penelope
Karanikola, Evridiki
Skifta, Evdoxia
Ardavanis, Alexandros S.
Raftopoulos, Vasilios 
Keywords: Serum CA 125;Ultrasonography;Cancer
Issue Date: 2004
Publisher: International Institute of Anticancer Research
Source: In Vivo, Vol.18, no.6, pp.831-836
Abstract: Background: The aim of this study was to evaluate the combination of serum CA125 and Transvaginal Ultra Sonography (TVUS) score, as a screening procedure for ovarian cancer in premenopausal and postmenopausal women. Patients and Methods: A retrospective case-control pilot study was conducted. The files of 120 women with ovarian neoplasia detected by TVUS and increased CA125 level, within the framework of a prevention program, were reviewed. The relationship between the above tests and epithelial malignancy was investigated using the SPSS-12 program for Windows. Results: The combination of CA125 value exceeding 30U/ml and a TVUS score ≥35 had a sensitivity of 81.7% and specificity of 100% in predicting ovarian cancer. Mathematical analysis of the logistic model of our variables revealed a mathematical model that can calculate the likelihood of ovarian cancer detection, by using a combination of CA125≥30U/ml and TVUS score≥35. Conclusion: By combining TVUS and CA125, an accurate prediction for the presence of ovarian cancer may be achieved. Further investigation in a larger population is warranted.
Description: Print issue issn: 0258-851X.
ISSN: 1791-7549
Rights: International Institute of Anticancer Research
Type: Article
Appears in Collections:Άρθρα/Articles

Files in This Item:
File Description SizeFormat
serum CA125.pdf93.85 kBAdobe PDFView/Open
Show full item record

Page view(s)

Last Week
Last month
checked on Aug 18, 2019


checked on Aug 18, 2019

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.